Use of Everolimus to treat cardiac rhabdomyomas and incessant arrhythmias in a newborn: Benefits and complications

Ann Pediatr Cardiol. 2022 Jan-Feb;15(1):58-60. doi: 10.4103/apc.apc_11_21. Epub 2022 Jun 14.

Abstract

We report treating a term neonate with tuberous sclerosis and giant rhabdomyomas who presented with incessant supraventricular tachycardia with Everolimus. The treatment was efficient in reducing tumor size and assisted as an adjunct therapy in controlling arrhythmia and limiting preexcitation. Treatment was challenged by difficulty to achieve stable drug level and limited by neutropenia as a serious side effect.

Keywords: Everolimus; Wolff-Parkinson-White; rhabdomyomas.

Publication types

  • Case Reports